91 related articles for article (PubMed ID: 16540525)
1. Quantitative assessment concerning the contribution of IL-2Rbeta for superantigen-mediated T cell responses in vivo.
Jin H; Gong D; Adeegbe D; Bayer AL; Rolle C; Yu A; Malek TR
Int Immunol; 2006 Apr; 18(4):565-72. PubMed ID: 16540525
[TBL] [Abstract][Full Text] [Related]
2. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
3. Superantigens anergize cytokine production but not cytotoxicity in vivo.
Sundstedt A; Dohlsten M; Hedlund G; Höidén I; Björklund M; Kalland T
Immunology; 1994 May; 82(1):117-25. PubMed ID: 7913912
[TBL] [Abstract][Full Text] [Related]
4. Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo.
Suzuki H; Zhou YW; Kato M; Mak TW; Nakashima I
J Exp Med; 1999 Dec; 190(11):1561-72. PubMed ID: 10587347
[TBL] [Abstract][Full Text] [Related]
5. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice.
Kneitz B; Herrmann T; Yonehara S; Schimpl A
Eur J Immunol; 1995 Sep; 25(9):2572-7. PubMed ID: 7589128
[TBL] [Abstract][Full Text] [Related]
6. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
Kuroda K; Yagi J; Imanishi K; Yan XJ; Li XY; Fujimaki W; Kato H; Miyoshi-Akiyama T; Kumazawa Y; Abe H; Uchiyama T
J Immunol; 1996 Aug; 157(4):1422-31. PubMed ID: 8759722
[TBL] [Abstract][Full Text] [Related]
7. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2.
Malek TR; Yu A; Vincek V; Scibelli P; Kong L
Immunity; 2002 Aug; 17(2):167-78. PubMed ID: 12196288
[TBL] [Abstract][Full Text] [Related]
8. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
9. Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin-2 pathway.
Gonzalo JA; Moreno de Alborán I; Alés-Martínez JE; Martínez C; Kroemer G
Eur J Immunol; 1992 Apr; 22(4):1007-11. PubMed ID: 1551401
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of V beta 8.2+ CD4+ T cells induced by a superantigen: roles of antigen-presenting cells and cytokines.
McKnight AJ; Shea CM; Wiens GR; Rimm IJ; Abbas AK
Immunology; 1994 Apr; 81(4):513-20. PubMed ID: 7913692
[TBL] [Abstract][Full Text] [Related]
11. Unique cytokine production profile of anergic human T cells in SCID-hu mice after staphylococcal enterotoxin B administration.
Schols D; Jones D; Roncarolo MG
J Immunol; 1995 Apr; 154(7):3204-12. PubMed ID: 7534791
[TBL] [Abstract][Full Text] [Related]
12. Resistance to tolerance induction in the diabetes-prone biobreeding rat as one manifestation of abnormal responses to superantigens.
Sellins KS; Gold DP; Bellgrau D
Diabetologia; 1996 Jan; 39(1):28-36. PubMed ID: 8720600
[TBL] [Abstract][Full Text] [Related]
13. Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivo.
Belfrage H; Dohlsten M; Hedlund G; Kalland T
Cancer Immunol Immunother; 1995 Aug; 41(2):87-94. PubMed ID: 7656274
[TBL] [Abstract][Full Text] [Related]
14. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
Ijichi S; Yamano Y; Osame M; Hall WW
Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
[TBL] [Abstract][Full Text] [Related]
15. Efficient induction of primary and secondary T cell-dependent immune responses in vivo in the absence of functional IL-2 and IL-15 receptors.
Yu A; Zhou J; Marten N; Bergmann CC; Mammolenti M; Levy RB; Malek TR
J Immunol; 2003 Jan; 170(1):236-42. PubMed ID: 12496405
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
[TBL] [Abstract][Full Text] [Related]
17. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
[TBL] [Abstract][Full Text] [Related]
18. Participation of Vbeta13(+) and Vbeta1(+) T cells in transfer thyroiditis after activation of mouse thyroglobulin-primed T cells by superantigen staphylococcal enterotoxin A.
Wan Q; Kita M; Flynn JC; Panos JC; Motte RW; Davies TF; Giraldo AA; David CS; Kong YC
Cell Immunol; 2001 Nov; 213(2):149-57. PubMed ID: 11831877
[TBL] [Abstract][Full Text] [Related]
19. The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens.
Litton MJ; Dohlsten M; Rosendahl A; Ohlsson L; Søgaard M; Andersson J; Andersson U
Br J Cancer; 1999 Sep; 81(2):359-66. PubMed ID: 10496366
[TBL] [Abstract][Full Text] [Related]
20. Long-term staphylococcal enterotoxin C1 exposure induces soluble factor-mediated immunosuppression by bovine CD4+ and CD8+ T cells.
Seo KS; Lee SU; Park YH; Davis WC; Fox LK; Bohach GA
Infect Immun; 2007 Jan; 75(1):260-9. PubMed ID: 17030573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
